Health Care/Hospital

PixCell Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA) for HemoScreen Point-of-Care Hematology Analyzer

YOKNEAM ILIT, Israel, Oct. 5, 2020 /PRNewswire/ -- PixCell Medical , innovator of rapid diagnostic solutions at the point-of-care, announced today that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for the HemoScre...

2020-10-05 08:00 2995

TaiGen filed US IND for its influenza antiviral TG-1000

TAIPEI, Taiwan, Oct. 4, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that it has filed an Investigational New Drug (IND) application with the US FDA for its influenza antiviral TG-1000. TG-1000 is a novel pan-influenza antiviral, which interrupts viral re...

2020-10-05 06:50 2373

iHerb Commits US $100 Million Investment in Russia to Better Serve Russian Communities

PASADENA, California, Oct. 3, 2020 /PRNewswire/ -- Global health and beauty e-commerce leader iHerb is committing US$100 million in Russia within the next two years to better serve Russian communities we have been privileged to support for many years. This commitment will include a varie...

2020-10-03 02:18 6644

Nordic Acquires Tasman Global

Healthcare consulting firm expands its reach to Europe and Asia MADISON, Wisconsin, Oct. 2, 2020 /PRNewswire/ -- Today, Nordic, a top-rated healthcare consulting firm, announced its acquisition ofTasman Global, a healthcare IT consulting company headquartered inthe Netherlands with offices throu...

2020-10-02 04:30 5529

Mentice to Acquire Vascular Simulations

STOCKHOLM, Oct. 2, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed a definitive agreement to acquire theNew York-based medical technology company Vascular Simulations (VSI), a world-leading provider of replication solutions allowing endovascular procedures to be performed by doctors mani...

2020-10-02 04:16 4249

mobilizationmagic.com Announces Kickstarter Campaign

SYDNEY, Oct. 2, 2020 /PRNewswire/ -- On October 3 2020 mobilizationmagic.com, a company dedicated to the betterment of human health through physiotherapy and design, launches the Kickstarter campaign for Mobilization Magic, a patented, researched mobilization tool to help reduce pain and increase...

2020-10-02 04:00 5758

Smartphone-based Solutions Boost the Global Infectious Disease Point-of-Care Testing Market at an Explosive CAGR of 70.2% in 2020

Digital POCT platforms will enable diagnostic testing beyond the clinic, transforming how assay results are gathered and analyzed, finds Frost & Sullivan SANTA CLARA, California, Oct. 2, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Smartphone-based Solutions Spur the Global Infectious ...

2020-10-02 03:43 3870

ZEISS at the 2020 Virtual ESCRS & EURETINA Congress

ZEISS Introduces New Solution Enhancements for Procedure Workflows at ESCRS and EURETINA JENA, Germany, Oct. 2, 2020 /PRNewswire/ -- ZEISS presents its new solution enhancements to help doctors maximize clinical efficiency and improve patient care - from assessment, diagnosis, to treatment. The ...

2020-10-02 03:16 3634

Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer

NANPING, China, Oct. 1, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's hand sanitizer products have been registered with U.S. Food and Drug Administra...

2020-10-01 22:00 13034

Technopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality-Control (QC) Platform Providing a Higher Level of Confidence in the Precision and Accuracy of Patient Sample Results

IAMQC Infinity™ is the first Software-as-a-Service (SaaS) platform for clinical laboratories to bring together worldwide peer comparisons, advanced QC analytics, proficiency testing data, and daily QC data management functions in real-time on one unified platform IAMQC Infinity empowers frontlin...

2020-10-01 14:00 5338

Growing Global Demand for ESP Disc Replacements Leads to Formation of Independent Company -- Spine Innovations to Launch October 1

HEIMSBRUNN, France, Oct. 1, 2020 /PRNewswire/ -- The growing global demand for ESP disc replacements has led to the creation of an independent company called Spine Innovations, scheduled to launch onOctober 1, 2020. The new company will take over the entire spine business of its parent company FH...

2020-10-01 06:00 2689

Concord Medical Announces a Hoisting Ceremony for the Proton Therapy System of Guangzhou Concord Cancer Center

BEIJING, Sept. 30, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone...

2020-10-01 05:00 15677

GVN's Top Virus Experts Meet Together To Identify Most Promising Advances To Battle COVID-19 & Strategies To Prepare For Future Pandemics

BALTIMORE, Oct. 1, 2020 /PRNewswire/ -- The Global Virus Network (GVN), a coalition of the world's leading medical and basic virology research centers working to prevent illness and death from viral disease, convened a press conference with attendees from across the globe to discuss key takeaways...

2020-10-01 04:56 5509

Turning AI onto itself: AI algorithm detects when medical images will be difficult for radiologists or AI to make an effective diagnosis

SAN FRANCISCO, Sept. 30, 2020 /PRNewswire/ -- A new AI algorithm can identify when medical images are likely to be difficult for either a radiologist or AI to make an effective diagnosis. The algorithm can potentially be used to triage medical scans and highlight cases that warrant further in-dep...

2020-09-30 23:06 1976

Harbour BioMed Announces Dosing of First Patients in Two Phase II Clinical Studies of Batoclimab (HBM9161) for the Treatment of Myasthenia Gravis and Immune Thrombocytopenia

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 30, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, bio-pharmaceutical company announced today the dosing of the first patient in two separate Phase II clinical trials of Batoclimab (HBM 9161), a fully human...

2020-09-30 21:50 5463

OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA

TOKYO, Sept. 30, 2020 /PRNewswire/ -- OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gene therapy and synthetic biology, has today launched the OriCiroTM Cell-Free Cloning System, the world's first technology enabling cell-free amplification...

2020-09-30 21:47 3212

Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- The clinical effectiveness of Getinge's patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient's own respiratory drive to control ventilator assistance, is supported in the NAVIATOR trial. According to the NAVIATOR trial, N...

2020-09-30 21:45 14189

Firmenich Opens New Era in Ingredient Creation with Launch of Biotech and Naturals Pilot Plant in Geneva

GENEVA, Switzerland, Sept. 30, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce the opening of its new biotechnology and naturals pilot plant and laboratory in Geneva. Benefiting from the latest digital technology, the facility ope...

2020-09-30 21:36 3730

MARii and Sengenics Launch ImmuSAFE® - World's First Multi-Antigen, Epitope Specific, Fully Quantitative COVID-19 Test

CYBERJAYA, Malaysia, Sept. 30, 2020 /PRNewswire/ -- The Malaysia Automotive, Robotics and IoT Institute (MARii) and Sengenics Sdn. Bhd. launched the ImmuSAFE COVID+ biochip, at MARii's headquarters, Cyberjaya. From left: Dr. Faizal Anwar, MAR...

2020-09-30 20:21 5988

I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency

SHANGHAI and GAITHERSBURG, Md., Sept. 30, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China Center for Drug Evaluation (CDE) has app...

2020-09-30 20:00 11794
1 ... 715716717718719720721 ... 848